Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AstraZeneca PLC Regulatory Filings 2019

Oct 4, 2019

5229_ffr_2019-10-04_5716a8ad-bb05-490b-980f-0895b5f85ca5.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 a8418o.htm HOLDING(S) IN COMPANY Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2019 Issuer Direct Corporation Blueprint

FORM 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Report of Foreign Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of October 2019

Commission File Number: 001-11960

AstraZeneca PLC

1 Francis Crick Avenue

Cambridge Biomedical Campus

Cambridge CB2 0AA

United Kingdom

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F X Form 40-F __

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes __ No X

If “Yes” is marked, indicate below the file number assigned to the Registrant in connection with Rule 12g3-2(b): 82-_______

AstraZeneca PLC

INDEX TO EXHIBITS

1.

Holding(s) in Company

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR
HOLDINGS (to be sent to
the relevant issuer and to
the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing
shares to which voting rights are attached: ASTRAZENECA
PLC
1b. Please indicate if the
issuer is a non-UK issuer (please mark with an "X" if
appropriate)
Non-UK
issuer
2. Reason for the
notification (please mark
the appropriate box or boxes with an "X")
An
acquisition or disposal of voting rights X
An
acquisition or disposal of financial instruments
An
event changing the breakdown of voting rights
Other
(please specify):
3. Details of person subject to the notification
obligation
Name Wellington
Management Company LLP
City
and country of registered office (if applicable) Boston,
USA
4. Full name of
shareholder(s) (if
different from 3)
Name Bank
of New York (Nominees) Ltd BBH
ISL NOMINEES LTD BNY
(OCS) Nominees Limited BNY
Mellon Nominees Limited GOLDMAN
SACHS INTERNATIONAL HSBC
Global Custody Nominee (UK) Limited Japan
Trustee Services Bank Ltd. JP
Morgan Chase Nominees Limited Mellon
Nominees (UK) Ltd. Nortrust
Nominees Limited ROY
Nominees Limited State
Street Nominees Limited VIDACOS
NOMINEES LIMITED
City
and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached: 01/10/2019
6. Date on which issuer notified (DD/MM/YYYY): 03/10/2019
7. Total positions of person(s) subject to the notification
obligation:
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B.1 + 8.B.2) Total of both in % (8.A + 8.B) Total number of voting rights of issuer
Resulting
situation on the date on which threshold was crossed or
reached 3.41% 2.47% 5.88% 1,311,894,438
Position
of previous notification (if applicable)
8. Notified details of the resulting situation on the date on which
the threshold was crossed or reached:
A: Voting rights attached to shares
Class/type of
shares ISIN code (if
possible) Number of voting rights % of voting rights
Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1) Direct (Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect (Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009895292 Ordinary Shares 44,759,495 3.41%
SUBTOTAL 8.A 44,759,495 3.41%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive
2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration date Exercise/ Conversion Period Number of voting rights that may be acquired if the instrument is
exercised/converted % of voting rights
Depository
Receipt 56,705,376
Depository Receipt shares or 28,352,661 votes on a converted
basis 2.16%
Depository
Receipt 6,875,371
Depository Receipt shares or 3,437,680 votes on a converted
basis 0.26%
Equity
Call Option 15/01/2021 01/01/1900to15/01/2021 1,137
Equity Call Option shares or 56,850 votes on a converted
basis 0.00%
Equity
Call Option 15/11/2019 01/01/1900to15/11/2019 476
Equity Call Option shares or 23,800 votes on a converted
basis 0.00%
SUBTOTAL 8.B.1 31,870,991 2.43%
B 2: Financial Instruments with similar economic effect according
to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1
(b))
Type of financial instrument Expiration date Exercise/ Conversion Period Physical or cash settlement Number of voting rights % of voting rights
Equity
Swap 31/01/2020 01/02/2019to31/01/2020 Cash 183,970
Equity Swap shares or 91,985 votes on a converted
basis 0.01%
Equity
Swap 29/05/2020 04/06/2019to29/05/2020 Cash 140,896
Equity Swap shares or 70,448 votes on a converted
basis 0.01%
Equity
Swap 31/03/2020 01/04/2019to31/03/2020 Cash 128,263
Equity Swap shares or 64,131 votes on a converted
basis 0.00%
Equity
Swap 30/04/2020 12/04/2019to30/04/2020 Cash 69,549
Equity Swap shares or 34,774 votes on a converted
basis 0.00%
Equity
Swap 30/06/2020 02/07/2019to30/06/2020 Cash 56,143
Equity Swap shares or 28,071 votes on a converted
basis 0.00%
Equity
Swap 31/08/2020 08/08/2019to31/08/2020 Cash 42,723
Equity Swap shares or 21,361 votes on a converted
basis 0.00%
Equity
Swap 15/05/2020 09/08/2018to15/05/2020 Cash 19,846
Equity Swap shares or 19,846 votes on a converted
basis 0.00%
Equity
Swap 20/05/2020 08/10/2018to20/05/2020 Cash 17,989
Equity Swap shares or 17,989 votes on a converted
basis 0.00%
Equity
Swap 15/05/2020 20/02/2019to15/05/2020 Cash 35,896
Equity Swap shares or 17,948 votes on a converted
basis 0.00%
Equity
Swap 30/04/2020 15/04/2019to30/04/2020 Cash 30,612
Equity Swap shares or 15,306 votes on a converted
basis 0.00%
Equity
Swap 30/04/2020 08/04/2019to30/04/2020 Cash 29,511
Equity Swap shares or 14,755 votes on a converted
basis 0.00%
Equity
Swap 15/05/2020 02/03/2018to15/05/2020 Cash 11,419
Equity Swap shares or 11,419 votes on a converted
basis 0.00%
Equity
Swap 20/05/2020 05/10/2018to20/05/2020 Cash 11,206
Equity Swap shares or 11,206 votes on a converted
basis 0.00%
Index
Future 01/10/2019 01/01/1900to01/10/2019 Cash 2,089
Index Future shares or 10,879 votes on a converted
basis 0.00%
Equity
Swap 15/05/2020 10/10/2017to15/05/2020 Cash 8,928
Equity Swap shares or 8,928 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 08/01/2019to20/05/2020 Cash 8,741
Equity Swap shares or 8,741 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 25/01/2019to20/05/2020 Cash 7,546
Equity Swap shares or 7,546 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 23/08/2019to20/05/2020 Cash 7,195
Equity Swap shares or 7,195 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 09/02/2018to15/05/2020 Cash 6,300
Equity Swap shares or 6,300 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 15/07/2019to20/05/2020 Cash 6,212
Equity Swap shares or 6,212 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 06/07/2018to20/05/2020 Cash 4,635
Equity Swap shares or 4,635 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 31/07/2019to05/05/2020 Cash 7,671
Equity Swap shares or 3,835 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 02/02/2018to15/05/2020 Cash 3,782
Equity Swap shares or 3,782 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 03/07/2018to20/05/2020 Cash 3,496
Equity Swap shares or 3,496 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 05/04/2018to20/05/2020 Cash 2,982
Equity Swap shares or 2,982 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 02/07/2018to15/05/2020 Cash 2,827
Equity Swap shares or 2,827 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 23/10/2017to15/05/2020 Cash 2,779
Equity Swap shares or 2,779 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 20/08/2019to05/05/2020 Cash 5,393
Equity Swap shares or 2,696 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 16/07/2018to15/05/2020 Cash 2,608
Equity Swap shares or 2,608 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 13/07/2018to20/05/2020 Cash 2,503
Equity Swap shares or 2,503 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 08/10/2018to20/05/2020 Cash 2,309
Equity Swap shares or 2,309 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 23/07/2018to20/05/2020 Cash 2,158
Equity Swap shares or 2,158 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 11/06/2018to15/05/2020 Cash 1,367
Equity Swap shares or 1,367 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 06/04/2018to20/05/2020 Cash 1,267
Equity Swap shares or 1,267 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 14/09/2018to20/05/2020 Cash 1,132
Equity Swap shares or 1,132 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 03/08/2018to20/05/2020 Cash 1,034
Equity Swap shares or 1,034 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 12/08/2019to05/05/2020 Cash 1,926
Equity Swap shares or 963 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 14/06/2019to15/05/2020 Cash 1,593
Equity Swap shares or 796 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 19/03/2018to20/05/2020 Cash 773
Equity Swap shares or 773 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 16/05/2019to15/05/2020 Cash 1,290
Equity Swap shares or 645 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 27/07/2018to15/05/2020 Cash 600
Equity Swap shares or 600 votes on a converted basis 0.00%
Index
Future 01/10/2019 01/01/1900to01/10/2019 Cash 96
Index Future shares or 501 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 15/08/2019to05/05/2020 Cash 841
Equity Swap shares or 420 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 13/08/2019to05/05/2020 Cash 834
Equity Swap shares or 417 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 02/08/2019to05/05/2020 Cash 818
Equity Swap shares or 409 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 26/07/2019to15/05/2020 Cash 647
Equity Swap shares or 323 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 25/06/2018to20/05/2020 Cash 314
Equity Swap shares or 314 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 21/05/2018to20/05/2020 Cash 200
Equity Swap shares or 200 votes on a converted basis 0.00%
Equity
Swap 15/05/2020 08/11/2018to15/05/2020 Cash 172
Equity Swap shares or 172 votes on a converted basis 0.00%
Equity
Swap 20/05/2020 03/10/2019to20/05/2020 Cash 162
Equity Swap shares or 162 votes on a converted basis 0.00%
Equity
Swap 05/05/2020 13/09/2019to05/05/2020 Cash 66
Equity Swap shares or 66 votes on a converted basis 0.00%
SUBTOTAL 8.B.2 523,211 0.04%

| 9. Information in relation to
the person subject to the notification
obligation (please mark
the applicable box with an "X") | | | |
| --- | --- | --- | --- |
| Person
subject to the notification obligation is not controlled by any
natural person or legal entity and does not control any other
undertaking(s) holding directly or indirectly an interest in the
(underlying) issuer. | | | |
| Full chain of controlled undertakings through
which the voting rights and/or the financial instruments are
effectively held starting with the ultimate controlling natural
person or legal entity (please add additional rows as
necessary) | | | X |
| Name | % of voting rights if it equals or is higher than the notifiable
threshold | % of voting rights through financial instruments if it equals or is
higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable
threshold |
| Wellington Management Company LLP | | | 5.88% |
| 10. In case of proxy voting, please identify: | | | |
| Name
of the proxy holder | | | |
| The
number and % of voting rights held | | | |
| The
date until which the voting rights will be held | | | |
| 11. Additional information: | | | |
| Place of completion | London | | |
| Date of completion | 03/10/2019 | | |

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

AstraZeneca PLC

Date: 04 October 2019

| By: /s/
Adrian Kemp |
| --- |
| Name:
Adrian Kemp |
| Title:
Company Secretary |

page break